OBJECTIVES A growing number of prospective clinical trials include economic end points. Recognizing the variation in methodology and reporting of these studies, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) chartered the Task Force on Good Research Practices: Randomized Clinical Trials-Cost-Effectiveness Analysis. Its goal was to develop a guidance document for d...

BACKGROUND AND PURPOSE The purpose of this review is to provide insight into the quality of economic evaluation in the field of cerebrovascular diseases (CVD) on the basis of a systematic analysis. METHODS A literature search was performed using several sources. Trial-based full economic evaluation studies, were included in this review. The quality of the studies was independently assessed by...

BACKGROUND With rising healthcare costs comes an increasing demand for evidence-informed resource allocation using economic evaluations worldwide. Furthermore, standardization of costing and reporting methods both at international and national levels are imperative to make economic evaluations a valid tool for decision-making. The aim of this review is to assess the availability and consistency...

INTRODUCTION The extraordinary feat of proving the effectiveness of oral pre-exposure prophylaxis (PrEP) in clinical trials in different populations in a variety of settings may prove to have been easier than ensuring it is used well. Decision-makers must make difficult choices to realize the promise of antiretroviral prophylaxis for their countries. This paper outlines key economic, regulatory...

Cost-effectiveness analysis (CEA), as a system of allocative efficiency for global health programs, is an influential criterion for resource allocation in the context of diplomacy and inherent foreign policy decisions therein. This is because such programs have diplomatic benefits and costs that can be uploaded from the recipient and affect the broader foreign policy interests of the donor and ...

Cost-effectiveness analysis (CEA) represents the most important tool in the health economics literature to quantify and qualify the reasoning behind the optimal decision process in terms of the allocation of resources to a given health intervention. However, the practical application of CEA in the regulatory process is often limited by some critical barriers, and decisions in clinical practice ...

BACKGROUND This study addresses the modelling and simulation of blood collection for fixed blood collection sites in a medium-sized large French city, as well as mobile blood collection in urban and rural environments. STUDY DESIGN AND METHODS Formal Petri net models were used to describe all relevant donor flows of the various blood collection systems; the Petri net models were converted ont...

is an economic evaluation tool that can be used to compare two or more programs or interventions. " It seems like a good program, but is it cost-effective? " is a question that is often asked about education programs. This article is designed to provide you with background information on cost-effectiveness analysis that may be helpful when responding to this question in relation to Reading Reco...

Today, participating in the organization's staff is one of the most basic ways to improve the efficiency and effectiveness of administrative and managerial countries, organizations and companies. According to increasing importance of human resources in organizations, this study was to investigate the relationship between human resource strategies with the participation of employees in the Natio...

BACKGROUND Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. METHODS The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog ...